Skip to main content
All lobbying clients

ASSOCIATION OF ACCESSIBLE MEDICINES

Lobbying client · District of Columbia · filed 2025 to 2026

Trade Association

$360,000 Reported spend
6 Filings counted
1 Firms hired
8 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (175633), not by name.

 Firms hired 1
 Bills named in these filings 8
  • HR 3269
    ETHIC Act
    5 filings
  • S 1040
    Drug Competition Enhancement Act
    5 filings
  • S 1954
    Biosimilar Red Tape Elimination Act
    5 filings
  • HR 1843
    To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
    4 filings
  • HR 5526
    Biosimilar Red Tape Elimination Act
    4 filings
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
    4 filings
  • S 43
    Skinny Labels, Big Savings Act
    4 filings
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
    2 filings
 Reported by year 2 years
  • 2026 $120,000 2 filings
  • 2025 $240,000 4 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6
  • Health & Human Services, Dept of (HHS) 1
  • Office of Management & Budget (OMB) 1

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem